Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Chen JF, Wu SW, Shi ZM, Hu B. Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action. Chin Med. 2023;18:14.

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233–54.

Article  PubMed  Google Scholar 

Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065.

Article  PubMed  PubMed Central  Google Scholar 

Lin T, Liang C, Peng W, Qiu Y, Peng L. Mechanisms of Core Chinese herbs against Colorectal Cancer: a study based on Data Mining and Network Pharmacology. Evid Based Complement Alternat Med. 2020;2020:8325076.

Article  PubMed  PubMed Central  Google Scholar 

Shao G, Liu Y, Lu L, Wang L, Ji G, Xu H. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug. J Ethnopharmacol. 2024;327:117999.

Article  CAS  PubMed  Google Scholar 

Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, Han J. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 2015;9:16–34.

Article  CAS  PubMed  Google Scholar 

Sun Q, He M, Zhang M, Zeng S, Chen L, Zhao H, Yang H, Liu M, Ren S, Xu H. Traditional Chinese Medicine and Colorectal Cancer: implications for Drug Discovery. Front Pharmacol. 2021;12:685002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu TG, Xiong SQ, Yan Y, Zhu H, Yi C. Use of Chinese herb medicine in cancer patients: a survey in southwestern China. Evid Based Complement Alternat Med. 2012;2012:769042.

Article  PubMed  PubMed Central  Google Scholar 

Zhou X, Peng Y, Liu B. Text mining for traditional Chinese medical knowledge discovery: a survey. J Biomed Inf. 2010;43:650–60.

Article  Google Scholar 

Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol. 2015;21:4466–90.

Article  PubMed  PubMed Central  Google Scholar 

L JDL, L J, Y C, Z H. L. L: Philosophical Thinking of Chinese Traditional Medicine. Tradit Med Mod Med. 2018:1–10.

Zhao X, Zheng X, Fan TP, Li Z, Zhang Y, Zheng J. A novel drug discovery strategy inspired by traditional medicine philosophies. Science. 2015;347:S38–40.

Google Scholar 

McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K, Colford JM Jr. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol. 2006;24:419–30.

Article  CAS  PubMed  Google Scholar 

Qiao L, Han M, Gao S, Shao X, Wang X, Sun L, Fu X, Wei Q. Research progress on nanotechnology for delivery of active ingredients from traditional Chinese medicines. J Mater Chem B. 2020;8:6333–51.

Article  CAS  PubMed  Google Scholar 

Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169.

Article  PubMed  PubMed Central  Google Scholar 

Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2023;10:1367–401.

Article  CAS  PubMed  Google Scholar 

Ali M, Wani SUD, Salahuddin M, S NM, Dey KM, Zargar T, Singh MI. Recent advance of herbal medicines in cancer- a molecular approach. Heliyon. 2023;9:e13684.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang R, Wang LQ, Yuan BC, Liu Y. The pharmacological activities of licorice. Planta Med. 2015;81:1654–69.

Article  CAS  PubMed  Google Scholar 

Shi X, Yu L, Zhang Y, Liu Z, Zhang H, Zhang Y, Liu P, Du P. Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway. Int Immunopharmacol. 2020;84:106578.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu SY, Wang WJ, Dou JH, Gong LK. Research progress on the protective effects of licorice-derived 18beta-glycyrrhetinic acid against liver injury. Acta Pharmacol Sin. 2021;42:18–26.

Article  CAS  PubMed  Google Scholar 

Wang G, Hiramoto K, Ma N, Yoshikawa N, Ohnishi S, Murata M, Kawanishi S. Glycyrrhizin attenuates carcinogenesis by inhibiting the inflammatory response in a murine model of Colorectal Cancer. Int J Mol Sci. 2021;22(5):2609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Z, Liu L, Gao C, Chen W, Vong CT, Yao P, Yang Y, Li X, Tang X, Wang S, Wang Y. Astragali Radix (Huangqi): a promising edible immunomodulatory herbal medicine. J Ethnopharmacol. 2020;258:112895.

Article  CAS  PubMed  Google Scholar 

Guo Z, Lou Y, Kong M, Luo Q, Liu Z, Wu J. A systematic review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: implications for Astragali Radix as a Personalized Medicine. Int J Mol Sci. 2019;20(6):1463.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lou Y, Guo Z, Zhu Y, Zhang G, Wang Y, Qi X, Lu L, Liu Z, Wu J. Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein. J Ethnopharmacol. 2019;228:82–91.

Article  CAS  PubMed  Google Scholar 

An L, Lin Y, Li L, Kong M, Lou Y, Wu J, Liu Z. Integrating Network Pharmacology and experimental validation to investigate the effects and mechanism of Astragalus flavonoids against hepatic fibrosis. Front Pharmacol. 2020;11:618262.

Article  CAS  PubMed  Google Scholar 

Zhao X, Li X, Ren Q, Tian J, Chen J. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERbeta/MiR-95 and IGF-1R, PI3K/Akt signaling pathways. Gene. 2016;591:123–8.

Article  CAS  PubMed  Google Scholar 

Feng Z, Yang R, Wu L, Tang S, Wei B, Guo L, He L, Feng Y. Atractylodes macrocephala polysaccharides regulate the innate immunity of colorectal cancer cells by modulating the TLR4 signaling pathway. Onco Targets Ther. 2019;12:7111–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang D, Li X, Song D, Chen S, Zhang Z, Cao S, Liu M. Atractylenolide III induces apoptosis by regulating the Bax/Bcl-2 signaling pathway in human colorectal cancer HCT-116 cells in vitro and in vivo. Anticancer Drugs. 2022;33:30–47.

Article  CAS  PubMed  Google Scholar 

Li Y, Wang Y, Liu Z, Guo X, Miao Z, Ma S. Atractylenolide I induces apoptosis and suppresses glycolysis by blocking the JAK2/STAT3 signaling pathway in Colorectal Cancer cells. Front Pharmacol. 2020;11:273.

Article  CAS  PubMed  PubMed Central